Live at interpack: Stevanato Group Showcases Development, Equipment Solutions

This week at interpack, Stevanato Group introduced drivers and benefits of implementing digitalization: from performance-enhancing to improvements in accuracy, efficiency, and overall quality.

Stevanato

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

This week at interpack, Stevanato Group presented its latest advances in automatic visual inspection, assembly, and packaging equipment for the pharmaceutical industry, such as MAVIS Combi, a state-of-the-art machine for automatic visual inspection.

MAVIS Combi:

  • Is suitable for any glass-filled drug container solution (syringes, vials, ampules, cartridges)
  • Inspects liquids, suspensions, gel-like and lyophilized substances
  • Performs advanced visual inspection with a small footprint
  • Achieves speeds up to 400 pieces/hr
  • Offers ease of use, installation, and maintenance
  • Provides enhanced safety and accuracy, costs reduction, optimized production timing

Stevanato Group also showcased a live demo of a high-speed auto-injector assembly line, designed to meet the market requirements for flexibility, efficiency, and scalability to streamline drug delivery device programs, at Interpack Booth #17A73.


Fill out the form below to request more information about Live at interpack: Stevanato Group Showcases Development, Equipment Solutions
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?